Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
13.07
+0.08 (0.62%)
At close: Dec 5, 2025, 4:00 PM EST
12.60
-0.47 (-3.60%)
After-hours: Dec 5, 2025, 7:42 PM EST
Crescent Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 |
| Dec '24 Dec 31, 2024 |
| Cash & Equivalents | 34.77 |
| Cash & Short-Term Investments | 34.77 |
| Prepaid Expenses | 0.04 |
| Total Current Assets | 34.8 |
| Long-Term Deferred Charges | 0.8 |
| Other Long-Term Assets | 0.01 |
| Accounts Payable | 0.11 |
| Accrued Expenses | 9.45 |
| Other Current Liabilities | 0.06 |
| Total Current Liabilities | 9.61 |
| Long-Term Debt | 37.48 |
| Common Stock | 0 |
| Additional Paid-In Capital | 2.39 |
| Retained Earnings | -17.87 |
| Total Common Equity | -15.48 |
| Total Liabilities & Equity | 35.62 |
| Total Debt | 37.48 |
| Net Cash (Debt) | -2.72 |
| Net Cash Per Share | -0.51 |
| Filing Date Shares Outstanding | 7.05 |
| Total Common Shares Outstanding | 7.05 |
| Working Capital | 25.19 |
| Book Value Per Share | -2.20 |
| Tangible Book Value | -15.48 |
| Tangible Book Value Per Share | -2.20 |
Source: S&P Capital IQ. Standard template.
Financial Sources.